Impact of Janus kinase inhibitors on the risk of cardiovascular events in patients with rheumatoid arthritis: systematic review and meta-analysis of randomised controlled trials

被引：3
|
作者：
Lee, Young Ho [1 ]
Song, Gwan Gyu [1 ]
机构：
[1] Korea Univ, Dept Rheumatol, Seoul, South Korea
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2020年 / 79卷 / 10期
关键词：
rheumatoid arthritis; cardiovascular disease; dmards (synthetic);
D O I：
10.1136/annrheumdis-2019-215815
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Impact of Janus kinase inhibitors on risk of cardiovascular events in patients with rheumatoid arthritis: systematic review and meta-analysis of randomised controlled trials
    Xie, Wenhui
    Huang, Yanrong
    Xiao, Shiyu
    Sun, Xiaoying
    Fan, Yong
    Zhang, Zhuoli
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 (08) : 1048 - 1054
  • [2] IMPACT OF JANUS KINASE INHIBITORS ON RISK OF CARDIOVASCULAR EVENTS IN PATIENTS WITH RHEUMATOID ARTHRITIS: SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
    Xie, Wenhui
    Xiao, Shiyu
    Huang, Yanrong
    Sun, Xiaoying
    Fan, Yong
    Zhang, Zhuoli
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 732 - 732
  • [3] Response to: 'Impact of Janus kinase inhibitors on the risk of cardiovascular events in patients with rheumatoid arthritis: systematic review and meta-analysis of randomised controlled trials' by Lee and Song
    Xie, Wenhui
    Xiao, Shiyu
    Zhang, Zhuoli
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 (10)
  • [4] MALIGNANCIES AND SERIOUS INFECTIONS IN RANDOMISED CONTROLLED TRIALS OF JANUS KINASE INHIBITORS IN PATIENTS WITH RHEUMATOID ARTHRITIS: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Lopez-Olivo, M. A.
    Tayar, J. H.
    Zamora, N. V.
    Pratt, G.
    Suarez-Almazor, M. E.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 66 - 66
  • [5] Risk of Cardiovascular and Venous Thromboembolic Events Associated With Janus Kinase Inhibitors in Rheumatoid Arthritis A Systematic Review and Network Meta-analysis
    Alves, Carlos
    Penedones, Ana
    Mendes, Diogo
    Marques, Francisco Batel
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2022, 28 (02) : 69 - 76
  • [6] Cardiovascular safety of Janus kinase inhibitors in patients with rheumatoid arthritis: systematic review and network meta-analysis
    Wei, Qige
    Wang, Hui
    Zhao, Jianglin
    Luo, Zhongping
    Wang, Chufeng
    Zhu, Chunmei
    Su, Na
    Zhang, Shengzhao
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [7] Malignancies and Serious Infections in Randomized Controlled Trials of Janus Kinase Inhibitors in Patients with Rheumatoid Arthritis: A Systematic Review and Meta-Analysis
    Lopez-Olivo, Maria A.
    Tayar, Jean
    Zamora, Natalia
    Pratt, Gregory
    Suarez-Almazor, Maria
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [8] Tocilizumab and the risk of respiratory adverse events in patients with rheumatoid arthritis: a systematic review and meta-analysis of randomised controlled trials
    Geng, Z.
    Yu, Y.
    Hu, S.
    Dong, L.
    Ye, C.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2019, 37 (02) : 318 - 323
  • [9] Effect of janus kinase inhibitors and methotrexate combination on malignancy in patients with rheumatoid arthritis: a systematic review and meta-analysis of randomized controlled trials
    Solipuram, Vinod
    Mohan, Akhila
    Patel, Roshniben
    Ni, Ruoning
    AUTOIMMUNITY HIGHLIGHTS, 2021, 12 (01)
  • [10] Impact of upadacitinib on the risk of digestive events in patients with rheumatoid arthritis: A systematic review and meta-analysis of randomized controlled trials
    Nie, Liu-yan
    Zhao, Kun
    Xu, Cheng
    Liu, Ming-hao
    Jin, Xue-xiao
    Han, Yong-mei
    HELIYON, 2023, 9 (06)
12345